Treatment costsCAR-T Cell Therapy Cost

Cell-therapy pricing

CAR-T Cell Therapy Cost in Germany for International Patients

Understand why CAR-T treatment requires an individualized German hospital quotation and which clinical and logistical components can materially affect the total cost.

By Treat in Germany Editorial TeamSources reviewed: 2026-08-29Independent clinician review: not yet claimed
Short answer: A single generic CAR-T price is not a safe basis for medical-travel budgeting. The total episode can include eligibility assessment, leukapheresis, cell-product manufacturing, bridging treatment, lymphodepleting chemotherapy, infusion, prolonged inpatient monitoring and treatment of serious complications. Charité's international-patient process states that the hospital provides a cost estimate for the expected stay after specialist review and requests upfront payment before admission.

Why an individual hospital estimate comes first

For international self-paying patients, a useful German quotation is normally prepared only after the medical records have been reviewed and the responsible clinical team has defined the expected treatment. The estimate may require advance payment and is later reconciled against the services actually delivered.

  • Medical-record review
  • Defined clinical treatment plan
  • Written cost estimate
  • Advance payment when required
  • Monitoring of additional services
  • Final invoice after treatment

CAR-T is a multi-stage treatment episode

The cost cannot be understood as the infusion alone. The clinical pathway may span several weeks and can change if the disease progresses, bridging therapy is needed, manufacturing is delayed or complications require intensive treatment.

Components that can materially affect the total

A quotation should be read together with the treatment plan.

  • Eligibility diagnostics and pathology review
  • Leukapheresis
  • Cell-product manufacturing
  • Bridging therapy when required
  • Lymphodepleting chemotherapy
  • CAR-T infusion
  • Inpatient monitoring
  • Management of cytokine-release syndrome or neurological toxicity
  • Follow-up blood tests, imaging and specialist visits

Ask what happens if the planned pathway changes

International patients should ask how additional hospital days, intensive care, unexpected medicines or a change in eligibility are handled financially. A preliminary estimate cannot guarantee that the original total will equal the final invoice.

Budget for the required stay near the treatment center

CAR-T programs may require the patient to remain close to the specialist center after infusion. Accommodation and companion costs can therefore be substantial even when they sit outside the hospital invoice.

Official sources

Last source-reviewed 2026-08-29. Cost procedures and published service fees can change, so confirm current terms directly with the provider before transferring money or booking travel.

Pricing notice: Treat in Germany does not issue hospital quotations and does not guarantee a treatment price. Hospital-specific published fees are examples, not national averages.
Verified centers

German centers documenting this service

These are not rankings or paid recommendations. Centers are displayed alphabetically by city and are included because their official websites document the relevant treatment, diagnostic test or specialist program. Availability for an individual patient still requires clinical review.

Aachen Center for Cell and Gene Therapy / Medical Clinic IV

Aachen · Uniklinik RWTH Aachen publishes a dedicated CAR-T program and specialist lymphoma/CAR-T consultation pathway within its hematology and oncology services.

Center for Cell Therapy and Stem Cell Transplantation Bonn

Bonn · University Hospital Bonn publishes a dedicated cell-therapy and stem-cell-transplantation center that provides CAR-T cell therapy for selected hematologic malignancies alongside autologous and allogeneic transplantation.

University Hospital Cologne CAR-T Program

Cologne · Cologne publishes a dedicated CAR-T program covering approved cellular therapies for lymphoma, leukemia and myeloma, with named CAR-T coordination contacts.

Hematology, Cell Therapy and Medical Oncology, University Hospital Dresden

Dresden · University Hospital Dresden explicitly lists CAR-T cells within its cellular-therapy program for malignant diseases of the blood-forming and lymphatic systems, alongside dedicated inpatient, outpatient and day-clinic follow-up pathways.

Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf

Düsseldorf · University Hospital Düsseldorf publishes CAR-T cell therapy as an established treatment within its hematology service for selected hematologic diseases including lymphomas and leukemias.

More verified centers13 additional centers

Medical Clinic 5 – Hematology and Medical Oncology, University Hospital Erlangen

Erlangen · University Hospital Erlangen explicitly lists CAR-T cell therapy among the modern cellular therapies provided by Medical Clinic 5 and publishes a dedicated CAR-T consultation for evaluation and follow-up.

Hospital profile → · Official program source ↗

Hematology and Stem Cell Transplantation, University Hospital Essen

Essen · University Hospital Essen publishes a dedicated CAR-T cell therapy pathway within its hematology and stem-cell-transplantation clinic, including specialist monitoring and a named CAR-T coordination service.

Hospital profile → · Official program source ↗

University Medical Center Freiburg CAR-T Program

Freiburg · Freiburg publishes a dedicated CAR-T treatment pathway within its hematology and oncology program and also provides an international-patient contact route.

Hospital profile → · Official program source ↗

UKE Department of Stem Cell Transplantation

Hamburg · UKE explicitly lists CAR-T cell therapy among the clinical focuses of its stem-cell transplantation and cell-therapy center for selected hematologic malignancies.

Hospital profile → · Official program source ↗

Heidelberg University Hospital Hematology / CAR-T Program

Heidelberg · Heidelberg University Hospital publishes a dedicated CAR-T treatment pathway and specialist assessment process within its hematology and cellular-therapy program.

Hospital profile → · Official program source ↗

Department of Internal Medicine I, Saarland University Hospital

Homburg · Saarland University Hospital publishes a cellular-therapy program in Internal Medicine I with CAR-T therapy for selected lymphoma patients and dedicated coordination for CAR-T treatment.

Hospital profile → · Official program source ↗

Department for Hematology, Cell Therapy and Hemostaseology, University Medical Center Leipzig

Leipzig · University Medical Center Leipzig explicitly lists CAR-T cell therapy within the treatment spectrum of its hematology and cell-therapy department.

Hospital profile → · Official program source ↗

Center for Cellular Immunotherapy and Stem Cell Transplantation, University Medical Center Mainz

Mainz · University Medical Center Mainz publishes a dedicated center for cellular immunotherapy and stem-cell transplantation that provides CAR-T cell therapy for selected hematological malignancies and multidisciplinary follow-up.

Hospital profile → · Official program source ↗

LMU Klinikum Medical Clinic III – CAR-T Program

Munich · LMU Klinikum publishes a dedicated CAR-T program with specialist treatment enquiries and inpatient monitoring pathways within Medical Clinic III.

Hospital profile → · Official program source ↗

UKM Hemato-Oncology / Bone Marrow Transplant Center

Münster · University Hospital Münster publishes a dedicated CAR-T program within its hematology and bone-marrow-transplant center and states that CAR-T treatment has been performed there since 2019 for selected hematologic malignancies.

Hospital profile → · Official program source ↗

Tübingen Center for Hematological Stem Cell Transplantation and Cell Therapy (ZZT)

Tübingen · University Hospital Tübingen states that its ZZT provides modern CAR-T cell therapies for children and adults and offers all approved commercial CAR-T products as well as selected locally manufactured cellular products.

Hospital profile → · Official program source ↗

Ulm Centre for Leukaemia, Lymphoma and Myeloma (ULLM)

Ulm · Ulm University Hospital states that CAR-T therapies are carried out in its hematology and transplant unit for selected hematological malignancies, and the unit is JACIE certified for CAR-T cell therapies.

Hospital profile → · Official program source ↗

Department of Internal Medicine II, University Hospital Würzburg

Würzburg · University Hospital Würzburg lists a large immunotherapy program including CAR-T cells within its hematology and oncology department.

Hospital profile → · Official program source ↗

Browse all verified centers → · Cost guide →